Vidal-Jordana A - Search Results

1

Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes.

Vidal-Jordana A, Sastre-Garriga J, Pérez-Miralles F, Tur C, Tintoré M, Horga A, Auger C, Río J, Nos C, Edo MC, Arévalo MJ, Castilló J, Rovira A, Montalban X. Vidal-Jordana A, et al. Mult Scler. 2013 Aug;19(9):1175-81. doi: 10.1177/1352458512473190. Epub 2013 Jan 14. Mult Scler. 2013. PMID: 23319072

2

Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision.

Tur C, Tintoré M, Vidal-Jordana A, Castilló J, Galán I, Río J, Arrambide G, Comabella M, Arévalo MJ, Horno R, Vicente MJ, Caminero A, Nos C, Sastre-Garriga J, Montalban X. Tur C, et al. Mult Scler. 2012 Aug;18(8):1193-6. doi: 10.1177/1352458512439238. Epub 2012 Mar 1. Mult Scler. 2012. PMID: 22383232

3

[Optical coherence tomography in multiple sclerosis].

Vidal-Jordana Á, Sastre-Garriga J, Montalban X. Vidal-Jordana Á, et al. Rev Neurol. 2012 May 1;54(9):556-63. Rev Neurol. 2012. PMID: 22532220 Free article. Review. Spanish.

4

Value of NMO-IgG determination at the time of presentation as CIS.

Costa C, Arrambide G, Tintore M, Castilló J, Sastre-Garriga J, Tur C, Río J, Saiz A, Vidal-Jordana A, Auger C, Nos C, Rovira A, Comabella M, Horga A, Montalban X. Costa C, et al. Neurology. 2012 May 15;78(20):1608-11. doi: 10.1212/WNL.0b013e3182563b32. Epub 2012 May 2. Neurology. 2012. PMID: 22551725

5

SIGLEC1 and SIGLEC7 expression in circulating monocytes of patients with multiple sclerosis.

Malhotra S, Castilló J, Bustamante M, Vidal-Jordana A, Castro Z, Montalban X, Comabella M. Malhotra S, et al. Mult Scler. 2013 Apr;19(5):524-31. doi: 10.1177/1352458512458718. Epub 2012 Aug 29. Mult Scler. 2013. PMID: 22933622

6

TRPM4 mRNA expression levels in peripheral blood mononuclear cells from multiple sclerosis patients.

Malhotra S, Castilló J, Negrotto L, Merino-Zamorano C, Montaner J, Vidal-Jordana A, Montalban X, Comabella M. Malhotra S, et al. J Neuroimmunol. 2013 Aug 15;261(1-2):146-8. doi: 10.1016/j.jneuroim.2013.05.013. Epub 2013 Jun 22. J Neuroimmunol. 2013. PMID: 23796873

7

Circulating levels of soluble apoptosis-related molecules in patients with multiple sclerosis.

Moreno M, Sáenz-Cuesta M, Castilló J, Cantó E, Negrotto L, Vidal-Jordana A, Montalban X, Comabella M. Moreno M, et al. J Neuroimmunol. 2013 Oct 15;263(1-2):152-4. doi: 10.1016/j.jneuroim.2013.07.013. Epub 2013 Jul 26. J Neuroimmunol. 2013. PMID: 23932896

8

Risk acceptance in multiple sclerosis patients on natalizumab treatment.

Tur C, Tintoré M, Vidal-Jordana Á, Bichuetti D, Nieto González P, Arévalo MJ, Arrambide G, Anglada E, Galán I, Castilló J, Nos C, Río J, Martín MI, Comabella M, Sastre-Garriga J, Montalban X. Tur C, et al. PLoS One. 2013 Dec 10;8(12):e82796. doi: 10.1371/journal.pone.0082796. eCollection 2013. PLoS One. 2013. PMID: 24340060 Free PMC article. Clinical Trial.

9

Comment on: 'Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients'.

Vidal-Jordana A, Tintoré M, Rovira A, Montalban X. Vidal-Jordana A, et al. Mult Scler. 2014 Jun;20(7):897-8. doi: 10.1177/1352458513515959. Epub 2013 Dec 18. Mult Scler. 2014. PMID: 24351437 No abstract available.

10

Comment on 'isolated bilateral horizontal gaze palsy as first manifestation of multiple sclerosis' by Stefan Kipfer and David W Crook.

Vidal-Jordana A. Vidal-Jordana A. Mult Scler. 2014 May;20(6):756. doi: 10.1177/1352458513518628. Epub 2014 Jan 9. Mult Scler. 2014. PMID: 24407770 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page